Page 4 - Dr Reddy 39 S News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dr reddy 39 s. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dr Reddy 39 S Today - Breaking & Trending Today

Dr. Reddy's expects first lot of Russia's COVID-19 vaccine Sputnik V by May-end


Updated:
April 27, 2021 12:37 IST
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus
Share Article
AAA
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus
Dr. Reddy’s Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, on April 27 said it expects the first lot of stock from Russian Direct Investment Fund (RDIF) by May-end.
In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the rights for distribution of the first 100 million doses in India. ....

Kirill Dmitriev , Gamaleya National Research Institute Of Epidemiology , Serum Institute Of India , Russian Direct Investment Fund , Gamaleya National Research Institute , Bharat Biotech , Serum Institute , Dr Reddy 39 S , Corona Virus , Sputnik V , Oxford Astrazeneca , Johnson Amp , Covid 19 Vaccination , Russian Covid 19 Vaccine , Covid 19 Vaccine , Phase 3 Trials , First Wave , Second Wave , Tika Utasav , Medical Oxygen , Oxygen Shortage , Oxygen Cylinder , Oxygen Cylinder Shortage , Vaccine Shortage , Bed Shortage , Vaccine Trials ,

Sensex falls by 244 points, UltraTech Cement top loser


Sensex falls by 244 points, UltraTech Cement top loser
ANI |
Updated: Apr 20, 2021 16:19 IST
Mumbai (Maharashtra) [India], Apr 20 (ANI): Equity benchmark indices failed to stick with early gains and closed half a per cent lower on Tuesday after a volatile session.
Despite the Covid-19 vaccine drive kindling hopes of recovery, investors said the market trend will depend on positive developments like a steep decline in infections and lifting of localised lockdown restrictions.
At the closing bell, the BSE S&P Sensex was down by 244 points or 0.51 per cent at 47,706 while the Nifty 50 edged lower by 63 points or 0.44 per cent to 14,296.
Sectoral indices at the National Stock Exchange were mixed green with Nifty IT down by 1.3 per cent, FMCG by 0.6 per cent and financial service by 0.5 per cent. But Nifty auto was up by 1 per cent and metal by 0.4 per cent. ....

India General , Hong Kong , Maruti Suzuki , Bajaj Finserv , Tata Motors , Bajaj Auto , Hindustan Lever , Eicher Motors , National Stock Exchange , Ultratech Cement , Shree Cement , Tech Mahindra , Bajaj Finance , South Korea , Covid 19 Vaccine Drive , Ocalised Lockdown Restrictions , Ultratech Cement , Hcl Technologies , Dr Reddy 39 S , Asian Shares , இந்தியா ஜநரல் , ஹாங் காங் , மாருதி ஸஸூகீ , பஜாஜ் பின்செருவ் , டாடா மோட்டார்கள் , பஜாஜ் ஆட்டோ ,

Sun Pharma, Dr Reddy's, Aurobindo recall products in the U.S. market


Dr Reddy s Laboratories is recalling 2,24,710 (500 count) bottles of Atorvastatin Calcium tablets.
Leading home grown drug makers Sun Pharma, Dr Reddy s Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the U.S. market, the world s largest market for pharmaceutical products, for various reasons.
As per the latest Enforcement Report by the U.S. Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, which is used to treat chronic dry eye.
The U.S.-based subsidiary of the Mumbai-based drug major is recalling 37,400 cartons (60 vials per carton) of the ophthalmic solution for being subpotent , the U.S. health regulator said. ....

United States , Andhra Pradesh , Sun Pharma , Aurobindo Pharma , Jubilant Cadista Pharmaceuticals , Drug Administration , Jubilant Life Sciences , Jubilant Pharma , Enforcement Report , Atorvastatin Calcium , Progesterone Capsules , Salisbury Based Jubilant Cadista Pharmaceuticals , Cadista Pharmaceuticals , Singapore Based Jubilant Pharma , Noida Based Jubilant Life , Us Food And Drug Administration , Dr Reddy 39 S , Product Recall , Pharmaceutical Products , Dr Reddy 39s Laboratories , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , சூரியன் பார்மா , அரவிந்தோ பார்மா , மகிழ்ச்சி வாழ்க்கை அறிவியல் , மகிழ்ச்சி பார்மா ,

'5 decades of vaccine excellence is paying off' - The Hindu BusinessLine


‘5 decades of vaccine excellence is paying off’
March 06, 2021
Suchitra Ella, Joint Managing Director of Bharat Biotech×
Bharat Bio’s Suchitra Ella says India will play a key role supplying Covid vaccines to the world
 
The near-five decades of vaccine manufacturing capability and excellence is paying off with Hyderabad set to play a significant role in the global supply chain of Covid-19 antidotes, said Suchitra Ella, Joint Managing Director of Bharat Biotech, which makes Covaxin.
Speaking at a CII conference on ‘Industry Reset: Summit on strategic manufacturing in digital era’, the Bharat Biotech co-founder said, “What started as an initiative driven by government institutions 4-5 decades ago, with significant participation of Indian research institutions for basic vaccines has now grown to become a big industry with India accounting for 60-65 per cent of global supplies of vaccines and Hyderabad accounting for about 70 per cent of India’s ....

Andhra Pradesh , Krishna Ella , Satish Reddy , Suchitra Ella , Dr Reddy Laboratory , Gemaleya Institute , Institute Of Virology , European Union , Joint Managing Director , Bharat Biotech , Industry Reset , Bharat Biotech Chairman , Managing Director Krishna Ella , National Institute , Drug Controller General , Emergency Use Authorisation , Covid 19 , Dr Reddy 39 S , ஆந்திரா பிரதேஷ் , கிருஷ்ணா எல்லா , சத்தீஷ் சிவப்பு , சூச்சித்ர எல்லா , டாக்டர் சிவப்பு ஆய்வகம் , நிறுவனம் ஆஃப் வைராலஜி , ஐரோப்பிய தொழிற்சங்கம் , கூட்டு நிர்வகித்தல் இயக்குனர் ,